This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Jamison Byrce Tuttle: Innovator in Triazine Derivatives
Introduction
Jamison Byrce Tuttle is a notable inventor based in Marblehead, MA (US). He has made significant contributions to the field of chemistry, particularly in the development of triazine derivatives. His work focuses on creating compounds that serve as inhibitors for specific enzymes, showcasing his innovative approach to pharmaceutical research.
Latest Patents
Jamison holds a patent for a new class of triazine derivatives, which are described by a specific formula. This invention is directed towards the use of these compounds as phosphodiesterase 10 (PDE10) inhibitors. His patent represents a significant advancement in the search for effective therapeutic agents.
Career Highlights
Jamison is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves extensive research and development, contributing to the advancement of new medications. His expertise in chemistry and innovative thinking have positioned him as a valuable asset to his team.
Collaborations
Throughout his career, Jamison has collaborated with talented individuals such as Christopher John Helal and Patrick Robert Verhoest. These partnerships have fostered a creative environment that encourages the exchange of ideas and enhances the development of new inventions.
Conclusion
Jamison Byrce Tuttle is a distinguished inventor whose work in triazine derivatives has the potential to impact the pharmaceutical industry significantly. His dedication to innovation and collaboration continues to drive advancements in medical research.